...
首页> 外文期刊>Preventive Nutrition and Food Science >Inhibitory Effect of 20(S)-Ginsenoside Rg3 on Human Platelet Aggregation and Intracellular Ca2+ Levels via Cyclic Adenosine Monophosphate Dependent Manner
【24h】

Inhibitory Effect of 20(S)-Ginsenoside Rg3 on Human Platelet Aggregation and Intracellular Ca2+ Levels via Cyclic Adenosine Monophosphate Dependent Manner

机译:20(S) - 喹啉醇RG3对人血小板聚集和细胞内Ca2 +水平的抑制作用通过环状腺苷依赖性方式

获取原文
获取原文并翻译 | 示例

摘要

Intracellular Ca2+ ([Ca2+]i) induces platelet aggregation, and influences the activation of aggregation associated-molecules. The increased [Ca2+]i activates both the Ca2+/calmodulin-dependent phosphorylation of the myosin light chain and the diacylglycerol-dependent phosphorylation of pleckstrin to trigger granule secretion (i.e., dense body and a-granule) and platelet aggregation. This study was carried out to elucidate the antagonistic effect of 20(S)-ginsenoside Rg3 (G-Rg3) present in Panax ginseng Mayer on Ca2+. G-Rg3 inhibited thrombin-induced human platelet aggregation in a dose-dependent manner and suppressed thrombin-induced elevation of [Ca2+]i mobilization. G-Rg3 increased the levels of cAMP, and subsequently, elevated the phosphorylationof inositol 1,4,5-triphosphate receptor I (Ser1756) during thrombin-induced human platelet aggregation. Moreover, G-Rg3 inhibited thapsigargin-induced Ca2+ influx and the thrombin-induced elevation of extracellular signal-regulated kinase 2 phosphorylation. G-Rg3 exhibited an inhibitory effect on [Ca2+]i levels leading to granule release and thus a therapeutic potential against platelet-mediated thrombotic disease is suggested.
机译:细胞内Ca 2 +([Ca2 +] I)诱导血小板聚集,并影响聚集相关分子的激活。增加的[Ca2 +] I激活肌球蛋白轻链的Ca2 + /钙调蛋白依赖性磷酸化和Pleckstrin的二酰基甘油依赖性磷酸化,以引发颗粒分泌(即,致密的身体和颗粒)和血小板聚集。进行该研究以阐明在CA2 +上存在于Panax人参Mayer中的20(S)-Ginsenide RG3(G-RG3)的拮抗作用。 G-RG3以剂量依赖性方式抑制凝血酶诱导的人血小板聚集,并抑制了[Ca2 +] I的凝血酶诱导的升高。 G-RG3增加营养水平,随后,在凝血酶诱导的人血小板聚集期间升高了肌醇1,4,5-三磷酸受体I(Ser1756)的磷酸化。此外,G-RG3抑制了ThapsIgargin-诱导的Ca2 +流入和凝血酶诱导的细胞外信号调节激酶2磷酸化的升高。 G-RG3表现出导致颗粒释放的[Ca2 +] I水平的抑制作用,因此提出了针对血小板介导的血栓疾病的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号